Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6193-6204

  Cannons, J L ^a   Choi, Y ^a   Watts, T H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; DENDRITIC CELL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REGULATION; IMMOBILIZED CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0034541168     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6193     Document Type: Article

References (66)

1. Differential T cell costimulatory requirements in CD28-deficient mice
2. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response
3. Skin allograft rejection in CD28-deficient mice
4. T cell costimulatory receptors other than CD28
5. Role of 4-1BB in immune responses
6. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor
7. - T lymphocytes by 4-1BB ligand
8. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
9. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
10. 4-1BB is a bona fide CD8 T cell survival signal
11. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
12. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway
13. 4-1BBL co-operates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long lasting anti-tumor vaccine
14. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and mice lacking both 4-1B B ligand and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
15. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP
16. - T cells
17. Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses
18. Costimulation of antigen-specific CD4 T cells by 4-1BB ligand
19. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
20. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination
21. Tumor necrosis factor receptor-associated factors (TRAFs): A family of adapter proteins that regulates life and death
22. JNK is involved in signal integration during costimulation of T lymphocytes
23. Costimulation-dependent activation of a JNK-kinase in T lymphocytes
24. Costimulation requirement for AP-1 and NF-κB transcription factor activation in T cells
25. Expression of constitutively active 1κBβ in T cells of transgenic mice: Persistent NF-κB activity is required for T-cell immune responses
26. IκB Kinase serve as a target of CD28 signaling
27. Early lethality, functional NF-κB activation and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
28. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival
29. 4-1BB and OX40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κb
30. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-κB
31. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB
32. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
33. ASK1 is essential for JNK/SAPK activation by TRAF2
34. Mediation of TNF receptor-associated factor effector function by apoptosis signal-regulating kinase-1 (ASK1)
35. From receptors to stress-activated MAP kinases
36. The p38 mitogen-activated protein kinase is activated by ligation of the T and B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors
37. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells
38. p38 Mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells
39. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: Dependence on CD28 signaling and preferential inhibition of IL-10 promoter
40. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-α production in a manner distinct from LPS activation of monocytes
41. p38 Mitogen-activated protein kinase regulates human T cell IL-5 synthesis
42. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
43. T cell proliferation in response to interleukin 2 and 7 requires p38 MAP kinase activation
44. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen activated protein kinase pathway
45. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4
46. Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction
47. Establishment and characterization of BALB/c lymphoma cell lines with B cell properties
48. Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class Il (1a) molecules
49. Derivation of a T cell line that is highly responsive to 1L-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S)
50. Identification of a monoclonal antibody specific for a murine T3 polypeptide
51. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method
52. Identification and distribution of the costimulatory receptor CD28 in the mouse
53. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells
54. Antigen presentation by supported planar membranes containing purified I-A(d)
55. 4-1BB T cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells
56. Molecular cloning and characterization of a novel protein kinase with catalytic domain homologous to mitogen-activated protein kinase kinase kinase
57. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
58. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
59. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors
60. + T cells and Th2 effector cells
61. Two types of murine helper T cell clone. I. Definition according to profiles of lymphocyte activities and secreted proteins
62. Activation of stress-activated protein kinase/c-jun N-terminal kinase, but not NF-κB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway
63. TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related
64. 2-terminal kinase (JNK) and p38
65. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
66. A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production